Awarded
Lote 1. Ravulizumab (Ultomiris).
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- ALEXION PHARMA SPAIN, S.L
- Contract value
- €5,854,033
- Bids received
- 1
- Published
- 3 Aug 2026
- Awarded
- 31 Jul 2026
- Contract start
- 31 Jul 2026
- Contract end
- 13 Aug 2027estimated
- Region
- Cantabria